Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 02, 2022
Jan. 01, 2022
Current assets:    
Cash and cash equivalents $ 41,315 $ 28,540
Restricted cash 36 41
Accounts receivable, net of allowance for credit losses of $1,049 and $1,212 149,883 134,561
Inventories, net 178,878 165,629
Income taxes receivable 2,685 2,762
Other current assets 17,481 20,101
Total current assets 390,278 351,634
Property, plant and equipment, net 168,860 174,210
Deferred income taxes 8,887 2,934
Goodwill 437,280 459,936
Other intangible assets, net 380,878 412,759
Other assets 19,481 13,873
Total assets 1,405,664 1,415,346
Current liabilities:    
Accounts payable 76,530 85,301
Accrued compensation and benefits 20,473 28,595
Other accrued expenses and current liabilities 35,099 28,254
Current portion of long-term non-revolving debt, net 19,157 18,125
Dividends payable 2,925 2,917
Income taxes payable 8,631 6,328
Total current liabilities 162,815 169,520
Revolving line of credit 223,827 242,312
Long-term non-revolving debt, net 173,807 183,897
Deferred income taxes 66,912 71,836
Other noncurrent liabilities 31,279 38,818
Total liabilities 658,640 706,383
Commitments and contingencies
Shareholders' equity:    
Preferred stock, par value $0.001, 2,000 shares authorized, no shares issued or outstanding 0 0
Common stock, par value $0.001, 100,000 shares authorized, 32,504 and 32,407 shares issued and outstanding 33 32
Capital in excess of par value 397,643 394,641
Retained earnings 417,944 363,279
Accumulated other comprehensive loss (68,596) (48,989)
Total shareholders' equity 747,024 708,963
Total liabilities and shareholders' equity $ 1,405,664 $ 1,415,346